Integrum: Solid performance in Q4 - Redeye

Redeye returns with a more in-depth take on the Q4’21/22 report and is encouraged that Integrum demonstrated significant sales growth. We believe its US focus will show even better results as we advance throughout the year, thanks to its intensified activities and as the pandemic eases up for elective surgeries.

Länk till analysen i sin helhet: https://www.redeye.se/research/846245/integrum-solid-performance-in-q4?utm_source=finwire&utm_medium=RSS